Biovista Competitors and Similar CompaniesClear all
Biovista's competitors and similar companies include Boundless Bio, Verseau Therapeutics and FoRx Therapeutics.
 Biovista Biovista is a company that provides drug repositioning and de-risking clinical solutions for the biopharma industry. |  Boundless Bio Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers. |  Verseau Therapeutics Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases. |  FoRx Therapeutics FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer. | |
Founding Date | Founding Date 2019 | Founding Date 2019 | Founding Date 2017 | Founding Date 2019 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Charlottesville, US HQ | Locations San Diego, US HQ | Locations Bedford, US HQ | Locations Basel, CH HQ |
Employees | Employees 205% decrease | Employees 2856% decrease | Employees 6 | Employees 343% increase |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 50m (over 6 years ago) | Latest funding round $ 10.8m (about 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 46.4m | Total funding raised $ 50m | Total funding raised $ 10.8m |
For sources of this data, please see the company profile
View Company Profiles
Boundless Bio
HQ
San Diego, US
Employees
28
Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers.
View companyVerseau Therapeutics
HQ
Bedford, US
Employees
6
Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases.
View companyFoRx Therapeutics
HQ
Basel, CH
Employees
34↑ 3% increase
FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer.
View company